Rx-Precision

Precision Medical Management

We improve outcomes and lower costs for high-risk, complex patient populations by tailoring
their medications to their DNA

The Problem

The Cost of Non-optimized Prescriptions

Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.

5

These “non-optimized” medications result in an estimated $528 billion in annual healthcare costs and $200 billion in unnecessary and inappropriate prescription drug utilization1

5

Adverse drug reactions, often caused by non-optimized medications are the fourth leading cause of death and account for 7% of all hospital admissions and 20% of readmissions2, 3

5

Furthermore, many important classes of drugs are effective in only 25-60 percent of the patient population4

A NEW APPROACH

PGx-Guided Care™

Identifies high-risk, high-cost employees and health plan members with complex chronic disease who have a medical necessity for a PGx test and guides them and their physician through the entire testing and medication optimization process

Medication Impact Analysis

Our proprietary technology leverages pharmacy, medical and eligibility claims data to identify the population that will clinically benefit from PGx testing and result in lower pharmacy and medical costs

Member Enrollment

Identified members receive education about the intervention via our certified enrollment specialists and are encouraged to participate in the program

Test Selection & Case Management

Members opting-in are matched to the optimal PGx panel and supported through a clinical genomic case management process. Rx-Precision is PGx Lab agnostic, so we can select the most appropriate panel for each member

Member Counseling & Physician Support

Each member is provided with genetic counseling and their physician is provided with a clinical action plan and peer-to-peer clinical decision support to implement recommended medication changes immediately

Outcomes Reporting

Payors receive comprehensive reports on member participation and satisfaction, post intervention drug-related morbidity and mortality reduction, pharmacy and medical spend reduction ROI. Employers also receive post-intervention data on absenteeism, presenteeism, productivity and stress reduction

Payor Benefits

agsdi-doctor

Precision Impact Analysis

Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing

agsdi-heartbeat

Improves Clinical Outcomes

Improves clinical outcomes for your high-risk, high-cost complex patients

agsdi-dollar

Lower Costs

Potentially lower pharmacy and medical costs for your highest-risk, complex patients

agsdi-flash

Improves Employee Productivity

Improved employee absenteeism, presenteeism and productivity

Billed as a Medical Claim

Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.

Let’s Get Started

Receive Your Complimentary Precision Impact Analysis for your health plan

Read More

For Payors

A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors

The Study

Pharmacogenomic testing and case management for members with complex chronic disease.

The Science

Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.

1. Annals of Pharamcotherapy, 2018. Vol. 52(9) 829-837

2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.

3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).

4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)

 

5. U.S. National Library of Medicine.

6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.

7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.

8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).

Resources

Privacy

Terms of Use

Copyright 2019 © Rx-Precision, Inc. All rights reserved.

Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361

Rx-Precision

Precision Medical Management

We improve outcomes and lower costs for high-risk, complex patient populations by tailoring
their medications to their DNA

The Problem

The Cost of Non-optimized Prescriptions

Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.

5

These “non-optimized” medications result in an estimated $528 billion in annual healthcare costs and $200 billion in unnecessary and inappropriate prescription drug utilization1

5

Adverse drug reactions, often caused by non-optimized medications are the fourth leading cause of death and account for 7% of all hospital admissions and 20% of readmissions2, 3

5

Furthermore, many important classes of drugs are effective in only 25-60 percent of the patient population4

A NEW APPROACH

PGx-Guided Care™

Identifies high-risk, high-cost employees and health plan members with complex chronic disease who have a medical necessity for a PGx test and guides them and their physician through the entire testing and medication optimization process

Medication Impact Analysis

Our proprietary technology leverages pharmacy, medical and eligibility claims data to identify the population that will clinically benefit from PGx testing and result in lower pharmacy and medical costs

Member Enrollment

Identified members receive education about the intervention via our certified enrollment specialists and are encouraged to participate in the program

Test Selection & Case Management

Members opting-in are matched to the optimal PGx panel and supported through a clinical genomic case management process. Rx-Precision is PGx Lab agnostic, so we can select the most appropriate panel for each member

Member Counseling & Physician Support

Each member is provided with genetic counseling and their physician is provided with a clinical action plan and peer-to-peer clinical decision support to implement recommended medication changes immediately

Outcomes Reporting

Payors receive comprehensive reports on member participation and satisfaction, post intervention drug-related morbidity and mortality reduction, pharmacy and medical spend reduction ROI. Employers also receive post-intervention data on absenteeism, presenteeism, productivity and stress reduction

Payor Benefits

agsdi-doctor

Precision Impact Analysis

Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing

agsdi-heartbeat

Improves Clinical Outcomes

Improves clinical outcomes for your high-risk, high-cost complex patients

agsdi-dollar

Lower Costs

Potentially lower pharmacy and medical costs for your highest-risk, complex patients

agsdi-people

Improves Employee Productivity

Improved employee absenteeism, presenteeism and productivity

Billed as a Medical Claim

Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.

Let’s Get Started

Receive Your Complimentary Precision Impact Analysis for your health plan

Read More

For Payors

A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors

The Study

Pharmacogenomic testing and case management for members with complex chronic disease.

The Science

Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.

1. Annals of Pharamcotherapy, 2018. Vol. 52(9) 829-837

2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.

3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).

4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)

5. U.S. National Library of Medicine.

6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.

7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.

8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).

Copyright 2019 © Rx-Precision, Inc. All rights reserved.

Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361